Search Results 2101-2110 of 18867 for Relapse
Each unique regimen or 'line' is defined as a single or combination of medications given for a new relapse/recurrence. Maintenance therapies, where ...
... relapse or who complete the Maintenance Study RPC01-3203, and subjects who complete a study of ozanimod for Crohn's Disease and meet the criteria for ...
This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
... relapsed/refractory multiple myeloma (RRMM). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
History of second malignancy, except those treated with curative intent more than five years previously without relapse or low likelihood of recurrence (for ...
Spencer did have one slight relapse, which manifested as another persistent headache in January of 2022 and sent him back to an ER in the Twin Cities. An ...
non-Hodgkin's lymphoma who relapse following chemotherapy. “BEXXAR is an intravenous monoclonal antibody that's directed against the proteins located in ...
This medicine will not cure MS, but it may slow some disabling effects and decrease the number of relapses of the disease. This medicine is available only ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!